Article
Author(s):
>Los Angeles-It's a simple axiom but one that appears to be appropriatewhen discussing radical prostatectomy: "Practice makes perfect."
Adjuvant pembrolizumab continues to show DFS, OS benefits for ccRCC at 5-year assessment
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
Perioperative sacituzumab govitecan/pembro yields compelling CR rate in MIBC
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
PEACE-3 data for radium-223/enzalutamide published in Annals of Oncology
Phase 2 trial launches of combination immunotherapy for mCRPC
EFS benefit is seen with sasanlimab in CIS and T1 NMIBC
Interim ENLIGHTED data show promise for padeliporfin VTP therapy in UTUC